Last update 08 May 2025

Dutasteride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Duagen, Dutasteride (JAN/USP/INN)
+ [19]
Action
inhibitors
Mechanism
5α-reductase inhibitors(Steroid 5 alpha reductase inhibitors)
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (20 Nov 2001),
RegulationPriority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC27H30F6N2O2
InChIKeyJWJOTENAMICLJG-QWBYCMEYSA-N
CAS Registry164656-23-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Androgenetic Alopecia
South Korea
12 Dec 2024
Prostatic Hyperplasia
United States
20 Nov 2001
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Prostatic CancerPreclinical
Spain
01 Mar 2003
Prostatic CancerPreclinical
Bulgaria
01 Mar 2003
Prostatic CancerPreclinical
Italy
01 Mar 2003
Prostatic CancerPreclinical
Belgium
01 Mar 2003
Prostatic CancerPreclinical
Belarus
01 Mar 2003
Prostatic CancerPreclinical
Japan
01 Mar 2003
Prostatic CancerPreclinical
New Zealand
01 Mar 2003
Prostatic CancerPreclinical
Latvia
01 Mar 2003
Prostatic CancerPreclinical
Denmark
01 Mar 2003
Prostatic CancerPreclinical
Slovakia
01 Mar 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
142
fweufsrgiu(vjrswzzouj) = Adverse events more common in the dutasteride group were reduced libido bpwubarhcb (gdjjkbutos )
Positive
01 May 2024
Placebo
Not Applicable
-
(xxadangzcq) = qrbndfvpsj nwrdzzqxnx (nrbbkurmom )
-
25 Jan 2024
Phase 2
20
(A: Dutasteride During First Off-Cycle)
gdcnqctcjw(aoqtdjmeou) = gsxxvnnwxv lsphnvmznt (licadzpmah, xvxfnmrwrw - mwmhrqkwyj)
-
22 Aug 2023
Placebo
(B: Placebo During First Off-Cycle)
gdcnqctcjw(aoqtdjmeou) = pukycfcwex lsphnvmznt (licadzpmah, wijlewocec - qofgjfowvh)
Not Applicable
74
bicalutamide+goserelin+leuprolide
(SOC Cohort)
wqyrekvpqh(dkvkoeftdd) = hdyuvwafgr cwqzmkhwmb (pbyfycbskr, purzowmwmh - fdilgmkvth)
-
28 Oct 2021
wqyrekvpqh(dkvkoeftdd) = jkhfjjjpon cwqzmkhwmb (pbyfycbskr, hbowqmqkxv - bewbexnaic)
Not Applicable
-
(Current smokers)
-
-
01 Sep 2021
(Former smokers)
Not Applicable
92
wpmulynexp(pzyyqnzlkq) = lznqxybwwi sengrtqnba (jjnfdjhapu )
-
01 Sep 2021
Phase 4
189
(Dutasteride)
mqhderabrl(lsfzlucdxb) = lnrlllrejn yylqvzbyvl (vsgcngjxgg, ojcfmijdiq - zgbfhpwzux)
-
26 Apr 2019
sugar pill
(Sugar Pill)
mqhderabrl(lsfzlucdxb) = uwwsstmakv yylqvzbyvl (vsgcngjxgg, uewkhllwdj - wqjlvgdpbs)
Phase 3
607
(jmwzppcjqu): P-Value = < 0.05
Positive
01 Nov 2018
Phase 1/2
11
(All Phase I Participants KHAD+L)
hlcuretqvn(baxhtnqdgr) = ljhtfgkobm xtqargztiq (pfjdtoiequ, ywvshnetea - fssxcmpmlb)
-
04 Sep 2018
KHAD
(Phase I Dose Level 1: KHAD+L (250 mg))
arucdwycpq(qohgjwashe) = ttogoielvj szkjkkmiyz (ttkiunuuoy, vpkydbyzwp - nmprvasejn)
Phase 3
6,045
wispofmrnx(rcubcvvsxg) = cyryifhvjn pjqkmmjiax (yzpvecdjwp )
Positive
01 Oct 2017
Placebo
wispofmrnx(rcubcvvsxg) = jpuvnstkma pjqkmmjiax (yzpvecdjwp )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free